Biotech

All Articles

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies will certainly specify on the NYSE American inventory exchange today thr...

ALX's fizzling CD47 action cost sends sell spiraling down

.ALX Oncology's stage 2 stomach cancer cells feedback cost has weakened. After observing its CD47 bl...

Ionis axes eye health condition coming from intendeds of Roche-partnered possibility after records dissatisfy

.One More of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of assumpt...

Biogen's chief executive officer stated no risky handle 2023. He's ready to be bold

.While Biogen's pharma peers are actually looking for late-stage resources along with little threat,...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has been a biotech trying to find a pipeline after it scrapped its lead resources ...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored civil liberties to an early Alzheimer's disease course to Denali Thera...

Takeda water faucets brand-new head people oncology business-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and als...

Vertex, hammered through AATD again, goes down 2 possessions on throw out heap

.Vertex's try to deal with an unusual hereditary condition has actually reached another obstacle. Th...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of team

.Vir Biotechnology's second-quarter profits document had not been except significant news. The provi...

Galapagos pauses CAR-T tissue therapy hearing over Parkinsonism case

.Galapagos has actually stopped application in a trial of a BCMA-directed CAR-T tissue therapy, pump...